Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
More Clues in the Case, but γ-Secretase Remains at Large

15 April 1999. In the search for the elusive γ-secretase that cleaves β-amyloid precursor protein (APP), much attention has been paid to the protein Notch, which is critical in developmental pathways and has recently been found to be important in immune function. Like APP, Notch is a membrane-spanning protein that appears to undergo proteolytic cleavage within the plasma membrane. Notch came to the attention of the Alzheimer's research community when it was discovered that homologues of the presenilins-critical for γ-secretase activity-were involved in the developmental signaling pathways of Notch. The question was posed as to whether γ-secretase is also involved in the cleavage of Notch. The relationship between the presenilins, Notch, and γ-secretase is explored in four papers in the April 8 issue of Nature.

Three of the papers focus on the relationship between presenilins and Notch, and two of these cover much of the same ground, coming to similar conclusions. Both Mark Fortini and his colleagues, and Gary Struhl and Iva Greenwald analyze Drosophila development with, and without, loss-of-function mutations in the presenilin gene. In the presence of presenilin mutations, each group finds lethal phenotypic changes related to Notch pathways. Fortini and colleagues further examine the resultant Notch species and conclude that the absence of presenilin prevents a crucial proteolytic cleavage event. Struhl and Greenwald are able to demonstrate that in the absence of presenilin, Notch is not capable of reaching the nucleus.

Working in presenilin-deficient murine fibroblasts, Bart De Strooper, Raphael Kopan, and their colleagues show a reduction in proteolysis of Notch in the absence of presenilin. They go on to identify the specific step in the Notch pathway that is affected by presenilin deficiency: the release of the Notch intracellular domain from the membrane. Finally, they construct a γ-secretase inhibitor from APP and demonstrate that it inhibits this same step in Notch processing.

Michael Wolfe, Dennis Selkoe, and colleagues add fuel to the argument that the presenilins are, in fact, γ-secretase. They demonstrate that two transmembrane aspartate residues in presenilin-1 are essential for APP cleavage and suggest that if the presenilins are not γ-secretase, they at least facilitate the activity of the protease involved in intramembrane cleavage. This view is echoed by Struhl and Greenwald and by De Strooper, Kopan, and colleagues.

A note of caution comes from John Hardy and Alain Israel in a News and Views article in the same issue. They opine that work to date, including these most recent results, do not show conclusively whether the presenilins act on the cleavage process or whether they are involved in trafficking upstream of the proteolytic events (as Fortini and colleagues suggest). Hardy and Israel also raise another critical point: Notch is not just a developmental player, but has a role in the formation of blood cells. Therefore, any targeting of γ-secretase to combat Alzheimer's disease may have unwanted immunosuppressive effects.-Hakon Heimer.

For further discussion, including Dennis Selkoe's response to points raised in the News and Views article, visit our interactive panel discussion on these papers.

References:
Ye Y, Lukinova N, Fortini ME. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 1999 Apr 8;398(6727):525-9. Abstract

Struhl G, Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 1999 Apr 8;398(6727):522-5. Abstract

De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999 Apr 8;398(6727):518-22. Abstract

Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 1999 Apr 8;398(6727):513-7. Abstract

Hardy J, Israel A. Alzheimer's disease. In search of gamma-secretase. Nature 1999 Apr 8;398(6727):466-7. Abstract

 
Comments on News and Primary Papers
  Primary Papers: Presenilin is required for activity and nuclear access of Notch in Drosophila.

Comment by:  Hiroshi Mori, ARF Advisor
Permalink

[Also] Unquestionably this is a core paper for AD study.

View all comments by Hiroshi Mori

  Primary Papers: Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants.

Comment by:  Hiroshi Mori, ARF Advisor
Permalink

Unquestionably this is a core paper for AD study.

View all comments by Hiroshi Mori

  Primary Papers: Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.

Comment by:  Hiroshi Mori, ARF Advisor
Permalink

Unquestionably this is a core paper for AD study.

View all comments by Hiroshi Mori

  Primary Papers: A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.

Comment by:  Hiroshi Mori, ARF Advisor
Permalink

Unquestionably this is a core paper for AD study.

View all comments by Hiroshi Mori

  Primary Papers: Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.

Comment by:  Andre Delacourte
Permalink

A turning point in the molecular history of neurodegenerative disorders.

View all comments by Andre Delacourte

  Primary Papers: Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants.

Comment by:  Andre Delacourte
Permalink

A turning point in the molecular history of neurodegenerative disorders.

View all comments by Andre Delacourte

  Primary Papers: Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.

Comment by:  Andre Delacourte, ARF Advisor
Permalink

A turning point in the molecular history of neurodegenerative disorders.

View all comments by Andre Delacourte

  Primary Papers: Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants.

Comment by:  Andre Delacourte, ARF Advisor
Permalink

A turning point in the molecular history of neurodegenerative disorders.

View all comments by Andre Delacourte

  Primary Papers: A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.

Comment by:  Paul Coleman, ARF Advisor
Permalink

The abstract states: 'Thus the targeting of gamma-secretase for the treatment of Alzheimer's disease may risk toxicity caused by reduced Notch signalling.' A potentially important cautionary note.

View all comments by Paul Coleman
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad